Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Hospital Medicine
Do you ever favor cefazolin over ceftriaxone for bacteremia with susceptible E. coli?
Answer from: at Community Practice
No
Sign in or Register to read more
24951
Related Questions
Have you incorporated the use of steroids for patients with severe community-acquired pneumonia?
When should antibiotics be discontinued for an immunocompetent patient with signs of meningoencephalitis who undergoes an LP without prior administration of antibiotics and the CSF shows a neutrophilic pleocytosis, negative Gram stain, negative PCR Panel, and negative CSF culture at day 3-5?
How would you approach treatment in a patient with refractory Coccidioidal meningitis who has previously been treated with IV amphotericin B?
For patients with candida species osteomyelitis who have undergone extensive surgical debridement, do you routinely still recommend 6-12 months of antifungal therapy or opt for a shorter duration?
How do you manage recurrent C diff which occurs shortly after FMT when alternate etiologies of diarrhea have been excluded and patient is responding to C diff-directed therapies?
Do you recommend treating Candida albicans on urine culture from dwelling catheter in a patient with septic shock?
Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?
Would you use ceftriaxone for treatment of a deep seated infection such as vertebral osteomyelitis +/- epidural abscess caused by a low risk AmpC producing pathogen?
What antibiotics would you use for empiric treatment of a brain abscess in patients allergic to penicillin, metronidazole, and vancomycin?
Which biomarkers or diagnostic tools do you prioritize to support the decision to start antifungal treatment in septic patients with no clear source of infection but at high risk for fungal infections?
